Dewulf J, Galanti L, Godet M, Gillet P, Jamart J, Hecq J-D
Medical Laboratory, CHU Dinant Godinne|UCL Namur, 1, avenue Thérasse, 5530 Yvoir, Belgium.
Medical Laboratory, CHU Dinant Godinne|UCL Namur, 1, avenue Thérasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU Dinant Godinne|UCL Namur, 1, avenue Thérasse, 5530 Yvoir, Belgium.
Ann Pharm Fr. 2015 Mar;73(2):108-13. doi: 10.1016/j.pharma.2014.10.003. Epub 2014 Dec 6.
The aim of the study was to investigate the long-term stability of acyclovir 5 mg/mL (a generic product versus the brand name) in NaCl 0.9% after storage at 5±3°C and to evaluate the influence of initial freezing and microwave thawing on this stability.
Five bags of Acyclovir® Hospira 5 mg/mL (A) and five bags of Zovirax® GSK 5 mg/mL (B) were prepared under aseptic conditions and stored 3 months at -20°C, then thawed and stored 30 days at 4°C. Five bags of Acyclovir® 5 mg/mL (C) and five bags of Zovirax® 5 mg/mL (D) were also prepared under aseptic conditions and stored 30 days at 5±3°C. Optic density measurement at different wavelengths, pH measurement and optic microscope observations were performed periodically during the storage. A forced degradation test with HCl 12 M and NaOH 5 M before and after heating at 100°C was also performed. The concentrations were measured by HPLC-PDA.
The only one forced degradation test that yielded chromatograms with degradation products peak was the test with the acid solution heated at 100°C without interference with the native product. No significant change in pH values or optic densities were seen during the study for both products. No crystals were seen with the optic microscope during the study. Acyclovir® and Zovirax® solutions were stable for at least 21 days according to the FDA recommendations. Moreover, there was no statistical difference between regression lines of those two products and two storage conditions.
Under the conditions of this study, Acyclovir® 5 mg/mL in 100 mL of NaCl 0.9% infusion remains stable at least for 21 days at 5±3°C with or without freezing at -20°C during the three previous months. There is no statistical difference between the brand name and a generic product. Acyclovir may be prepared in advanced by a centralized intravenous additive service, frozen in polyolefin bags and microwave thawed before storage under refrigeration until 21 days.
本研究的目的是调查5毫克/毫升阿昔洛韦(一种仿制药与品牌药)在0.9%氯化钠溶液中于5±3°C储存后的长期稳定性,并评估初始冷冻和微波解冻对其稳定性的影响。
在无菌条件下制备五袋5毫克/毫升的阿昔洛韦 Hospira(A)和五袋5毫克/毫升的泛昔洛韦 GSK(B),在-20°C储存3个月,然后解冻并在4°C储存30天。还在无菌条件下制备五袋5毫克/毫升的阿昔洛韦(C)和五袋5毫克/毫升的泛昔洛韦(D),并在5±3°C储存30天。在储存期间定期进行不同波长的光密度测量、pH测量和光学显微镜观察。还在100°C加热前后用12M盐酸和5M氢氧化钠进行强制降解试验。通过高效液相色谱-光电二极管阵列检测法测量浓度。
唯一产生带有降解产物峰的色谱图的强制降解试验是在100°C加热的酸性溶液试验,且未干扰天然产物。在研究期间,两种产品的pH值和光密度均未出现显著变化。研究期间光学显微镜下未观察到晶体。根据美国食品药品监督管理局的建议,阿昔洛韦和泛昔洛韦溶液至少21天稳定。此外,这两种产品在两种储存条件下的回归线之间没有统计学差异。
在本研究条件下,100毫升0.9%氯化钠注射液中5毫克/毫升的阿昔洛韦,无论前三个月是否在-20°C冷冻,在5±3°C至少可稳定21天。品牌药和仿制药之间没有统计学差异。阿昔洛韦可由集中静脉添加剂服务提前制备,冷冻在聚烯烃袋中,在冷藏储存前微波解冻直至21天。